Skip to content
Review

Long non-coding RNAs as determinants of cell fate in gastric cancer: Molecular mechanisms governing survival and programmed cell death.

Sep 2026 · Biochimica et Biophysica Acta - Molecular Basis of Disease · Vol 1873, pp. 168469 · 0 citations · 302 references
Medicine

TL;DR

Overall, available evidence identifies lncRNAs as key mediators of gastric carcinogenesis and as potential diagnostic biomarkers and therapeutic targets.

Abstract

Long non-coding RNAs (lncRNAs) are now recognized as important modulators of gene expression acting at the transcriptional, post-transcriptional, and epigenetic levels. A growing number of studies suggest that abnormal lncRNA expression plays a critical role in gastric carcinogenesis by controlling cellular functions such as proliferation, cell-cycle progression, apoptosis, autophagy, and other forms of regulated cell death. This review discusses the molecular pathways through which lncRNAs contribute to gastric carcinogenesis, particularly by regulating cell fate, proliferation, and apoptosis. We also summarize the functions of major oncogenic and tumor-suppressive lncRNAs, including HOTAIR, MALAT1, H19, GAS5, DINO, PANDAR and their associations with PI3K/AKT, Wnt/β-catenin, MAPK, JAK/STAT, and p53 signaling. Associations among lncRNAs, ferroptosis, treatment response, and tumor progression are also discussed. Overall, available evidence identifies lncRNAs as key mediators of gastric carcinogenesis and as potential diagnostic biomarkers and therapeutic targets.

View source

Similar papers

Review Open access Sep 2026

Long non-coding RNA GAS6-AS1 and its molecular mechanisms in human cancer (Review)

GAS6-AS1 represents a promising molecule for understanding cancer pathogenesis and developing novel strategies for precision cancer diagnosis and treatment, although further clinical validation and mechanistic studies are still required.

Zhi-Ling Lu, Wen-Bing Huang, Jin-Tao He et al. · 0 citations
Review Open access Sep 2026

From epigenetics to metastasis: Multifaceted roles of lncRNAs in gastric cancer

This review provides a comprehensive overview of the current understanding of lncRNA-mediated regulation of EMT and metastasis in gastric cancer and provides insights into the complex regulatory networks governed by lncRNAs, highlighting their translational potential in improving GC management.

M. Saadh, A. K. Bishoyi, R. Roopashree et al. · 0 citations
#gene editing Review Open access Aug 2026

The emerging roles of non-coding RNAs in cancer.

This review examines how different types of ncRNAs contribute to cancer initiation, progression, and treatment resistance, and assesses their potential as diagnostic markers, prognostic factors, and therapeutic targets.

Akanksha Samuel, G. Calin · 0 citations
Review 2026

Non-coding RNAs related to PD1/PD-L1 signaling with potential diagnostic, prognostic, and therapeutic value in the tumorigenesis of brain cancers

A review of recent advances in understanding the regulatory role of ncRNAs on the PD-1/ PD-L1 pathway in brain cancer tumorigenesis highlights promising opportunities for developing therapeutic interventions against brain cancer.

Reihane Behnam-Rassouli, Farzaneh Entezari, Majid Ghorbanzadeh et al. · 0 citations
#protein folding Open access Oct 2026

Long Non-Coding RNA LINC01614 Promotes Aggressive Phenotypes and Ferroptosis Resistance in Papillary Thyroid Cancer Through a Putative miR-4521/IGF2/PI3K-AKT Signaling Axis

Background/Objectives: Papillary thyroid cancer (PTC) is the most common endocrine malignancy and is generally associated with favorable clinical outcomes. However, a subset of tumors develops aggressive phenotypes characterized by increased proliferation, migration, therapeutic resistance, and disease progression. Lon...

D. Quaranto, N. DeSouza, Michelle Carnazza et al. · 0 citations
Open access Jan 2026

Integrative Pan‐Cancer Characterization of lncRNA UPK1A‐AS1 and Its Role in Hypoxia‐Associated Sorafenib Resistance in Hepatocellular Carcinoma

It is suggested that UPK1A-AS1 is a hypoxia‐inducible oncogenic lncRNA that plays dual roles in cancer, with cancer type‐dependent associations with progression and immune modulation across malignancies and mechanistically mediating hypoxia‐associated drug resistance in HCC.

Ze-Kai Li, Min Luo, Shu-Sen Fang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.